Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122998236 | 12299823 | 6 | F | 20150921 | 20160721 | 20160425 | 20160804 | EXP | HU-PFIZER INC-2015321756 | PFIZER | 59.00 | YR | M | Y | 0.00000 | 20160804 | OT | HU | HU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122998236 | 12299823 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY, 1ST CYCLE | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122998236 | 12299823 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY, 2ND CYCLE | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122998236 | 12299823 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY, 3RD CYCLE | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122998236 | 12299823 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY, 4TH CYCLE | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122998236 | 12299823 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY, 6TH CYCLE | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122998236 | 12299823 | 6 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY THROUGH 4 WEEKS | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122998236 | 12299823 | 7 | C | VEROSPIRON | SPIRONOLACTONE | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122998236 | 12299823 | 1 | Renal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122998236 | 12299823 | HO |
| 122998236 | 12299823 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122998236 | 12299823 | Blood thyroid stimulating hormone increased | |
| 122998236 | 12299823 | Bronchial obstruction | |
| 122998236 | 12299823 | Choking | |
| 122998236 | 12299823 | Diarrhoea | |
| 122998236 | 12299823 | Dyspnoea | |
| 122998236 | 12299823 | Fatigue | |
| 122998236 | 12299823 | Hypertension | |
| 122998236 | 12299823 | Oral pain | |
| 122998236 | 12299823 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122998236 | 12299823 | 1 | 20150909 | 2015 | 0 | |
| 122998236 | 12299823 | 2 | 20151020 | 20151116 | 0 | |
| 122998236 | 12299823 | 3 | 20151130 | 0 | ||
| 122998236 | 12299823 | 4 | 20160111 | 0 | ||
| 122998236 | 12299823 | 5 | 20160406 | 0 | ||
| 122998236 | 12299823 | 6 | 20160517 | 0 |